A legitimate provider will check your BMI, medical history, current medicines and whether treatment is clinically suitable before prescribing
The 24% Breakthrough: In Phase 2 trials, Retatrutide showed a mean weight reduction of 24.2% at the highest dose, the highest percentage ever recorded for a weight-loss drug in this timeframe. Liver Health Bonus: Research indicates that Retatrutide is exceptionally effective at clearing fat from the liver, showing over 80% reduction in liver fat for many patients
Retatrutide is known as a triple agonist
Back Unger, RH, Ketterer, H Dupr, J, Eisentraut, I (1967) 'The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs', Journal Clinical Investigation , 46/4, 63045
Tirzepatide's mechanism stays within incretin pathways, which is why its weight-loss ceiling sits below retatrutide's in head-to-head modelling